对TEAD调制器 (2022年至今) 的最新专利审查
Dounan Xu1,2, Jiahuan Zhong1,2, Yuhan Zeng2,3
1School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou, China.
Expert opinion on therapeutic patents
|June 19, 2025
概括
针对转录增强关联域 (TEAD) 蛋白的小分子抑制剂对于癌症治疗至关重要. 最近的专利揭示了新的TEAD调节器和组合疗法,在临床试验中显示出有希望的结果.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 药物发现 药物发现 药物发现
背景情况:
- 转录增强关联域 (TEAD) 家族在河马信号通路中起着至关重要的作用,调节关键细胞过程.
- TEAD抑制是癌症治疗的关键策略,有几种化合物在临床试验中.
研究的目的:
- 审查最近关于小分子TEAD抑制剂和降解剂的专利文献.
- 将之前的专利审查 (2018-2022) 更新为2022年6月至2025年3月的数据.
主要方法:
- 对TEAD调制器发表的专利文献进行分析.
- TEAD调节剂的分类为非共价抑制剂,共价抑制剂,蛋白质-蛋白质相互作用抑制剂和降解剂.
主要成果:
- 在最近的专利中描述的各种TEAD调制器的识别.
- 证明了涉及TEAD抑制剂的组合疗法的有前途的治疗效果.
结论:
- TEAD调节器是癌症治疗药物开发的一个重要领域.
- 涉及TEAD抑制剂的组合策略在治疗各种癌症方面具有广泛的适用性.
相关概念视频
Drug Regulation
1.9K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.9K
Clinical Trials: Overview
3.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.4K
Drug Administration and Therapy Phases: Overview
779
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
779
Preclinical Development: Overview
4.9K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.9K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
184
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
184
Allosteric Regulation
59.2K
Allosteric regulation of enzymes occurs when the binding of an effector molecule to a site that is different from the active site causes a change in the enzymatic activity. This alternate site is called an allosteric site, and an enzyme can contain more than one of these sites. Allosteric regulation can either be positive or negative, resulting in an increase or decrease in enzyme activity. Most enzymes that display allosteric regulation are metabolic enzymes involved in the degradation or...
59.2K


